Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.

Natarajan P, Pampana A, Graham SE, Ruotsalainen SE, Perry JA, de Vries PS, Broome JG, Pirruccello JP, Honigberg MC, Aragam K, Wolford B, Brody JA, Antonacci-Fulton L, Arden M, Aslibekyan S, Assimes TL, Ballantyne CM, Bielak LF, Bis JC, Cade BE, Do R, Doddapaneni H, Emery LS, Hung YJ, Irvin MR, Khan AT, Lange L, Lee J, Lemaitre RN, Martin LW, Metcalf G, Montasser ME, Moon JY, Muzny D, O'Connell JR, Palmer ND, Peralta JM, Peyser PA, Stilp AM, Tsai M, Wang FF, Weeks DE, Yanek LR, Wilson JG, Abecasis G, Arnett DK, Becker LC, Blangero J, Boerwinkle E, Bowden DW, Chang YC, Chen YI, Choi WJ, Correa A, Curran JE, Daly MJ, Dutcher SK, Ellinor PT, Fornage M, Freedman BI, Gabriel S, Germer S, Gibbs RA, He J, Hveem K, Jarvik GP, Kaplan RC, Kardia SLR, Kenny E, Kim RW, Kooperberg C, Laurie CC, Lee S, Lloyd-Jones DM, Loos RJF, Lubitz SA, Mathias RA, Martinez KAV, McGarvey ST, Mitchell BD, Nickerson DA, North KE, Palotie A, Park CJ, Psaty BM, Rao DC, Redline S, Reiner AP, Seo D, Seo JS, Smith AV, Tracy RP, Vasan RS, Kathiresan S, Cupples LA, Rotter JI, Morrison AC, Rich SS, Ripatti S, Willer C, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, FinnGen, Peloso GM

Open source

DOI
10.1038/s41467-021-22339-1
Published
2021 Apr 12
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-021-22339-1,
  title = {Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.},
  author = {Natarajan P and Pampana A and Graham SE and Ruotsalainen SE and Perry JA and de Vries PS and Broome JG and Pirruccello JP and Honigberg MC and Aragam K and Wolford B and Brody JA and Antonacci-Fulton L and Arden M and Aslibekyan S and Assimes TL and Ballantyne CM and Bielak LF and Bis JC and Cade BE and Do R and Doddapaneni H and Emery LS and Hung YJ and Irvin MR and Khan AT and Lange L and Lee J and Lemaitre RN and Martin LW and Metcalf G and Montasser ME and Moon JY and Muzny D and O'Connell JR and Palmer ND and Peralta JM and Peyser PA and Stilp AM and Tsai M and Wang FF and Weeks DE and Yanek LR and Wilson JG and Abecasis G and Arnett DK and Becker LC and Blangero J and Boerwinkle E and Bowden DW and Chang YC and Chen YI and Choi WJ and Correa A and Curran JE and Daly MJ and Dutcher SK and Ellinor PT and Fornage M and Freedman BI and Gabriel S and Germer S and Gibbs RA and He J and Hveem K and Jarvik GP and Kaplan RC and Kardia SLR and Kenny E and Kim RW and Kooperberg C and Laurie CC and Lee S and Lloyd-Jones DM and Loos RJF and Lubitz SA and Mathias RA and Martinez KAV and McGarvey ST and Mitchell BD and Nickerson DA and North KE and Palotie A and Park CJ and Psaty BM and Rao DC and Redline S and Reiner AP and Seo D and Seo JS and Smith AV and Tracy RP and Vasan RS and Kathiresan S and Cupples LA and Rotter JI and Morrison AC and Rich SS and Ripatti S and Willer C and NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium and FinnGen and Peloso GM},
  year = {2021},
  journal = {Nature communications},
  doi = {10.1038/s41467-021-22339-1},
  url = {https://doi.org/10.1038/s41467-021-22339-1}
}

RIS

TY  - JOUR
TI  - Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.
AU  - Natarajan P
AU  - Pampana A
AU  - Graham SE
AU  - Ruotsalainen SE
AU  - Perry JA
AU  - de Vries PS
AU  - Broome JG
AU  - Pirruccello JP
AU  - Honigberg MC
AU  - Aragam K
AU  - Wolford B
AU  - Brody JA
AU  - Antonacci-Fulton L
AU  - Arden M
AU  - Aslibekyan S
AU  - Assimes TL
AU  - Ballantyne CM
AU  - Bielak LF
AU  - Bis JC
AU  - Cade BE
AU  - Do R
AU  - Doddapaneni H
AU  - Emery LS
AU  - Hung YJ
AU  - Irvin MR
AU  - Khan AT
AU  - Lange L
AU  - Lee J
AU  - Lemaitre RN
AU  - Martin LW
AU  - Metcalf G
AU  - Montasser ME
AU  - Moon JY
AU  - Muzny D
AU  - O'Connell JR
AU  - Palmer ND
AU  - Peralta JM
AU  - Peyser PA
AU  - Stilp AM
AU  - Tsai M
AU  - Wang FF
AU  - Weeks DE
AU  - Yanek LR
AU  - Wilson JG
AU  - Abecasis G
AU  - Arnett DK
AU  - Becker LC
AU  - Blangero J
AU  - Boerwinkle E
AU  - Bowden DW
AU  - Chang YC
AU  - Chen YI
AU  - Choi WJ
AU  - Correa A
AU  - Curran JE
AU  - Daly MJ
AU  - Dutcher SK
AU  - Ellinor PT
AU  - Fornage M
AU  - Freedman BI
AU  - Gabriel S
AU  - Germer S
AU  - Gibbs RA
AU  - He J
AU  - Hveem K
AU  - Jarvik GP
AU  - Kaplan RC
AU  - Kardia SLR
AU  - Kenny E
AU  - Kim RW
AU  - Kooperberg C
AU  - Laurie CC
AU  - Lee S
AU  - Lloyd-Jones DM
AU  - Loos RJF
AU  - Lubitz SA
AU  - Mathias RA
AU  - Martinez KAV
AU  - McGarvey ST
AU  - Mitchell BD
AU  - Nickerson DA
AU  - North KE
AU  - Palotie A
AU  - Park CJ
AU  - Psaty BM
AU  - Rao DC
AU  - Redline S
AU  - Reiner AP
AU  - Seo D
AU  - Seo JS
AU  - Smith AV
AU  - Tracy RP
AU  - Vasan RS
AU  - Kathiresan S
AU  - Cupples LA
AU  - Rotter JI
AU  - Morrison AC
AU  - Rich SS
AU  - Ripatti S
AU  - Willer C
AU  - NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
AU  - FinnGen
AU  - Peloso GM
PY  - 2021
JO  - Nature communications
DO  - 10.1038/s41467-021-22339-1
UR  - https://doi.org/10.1038/s41467-021-22339-1
ER  - 

APA

P, N., A, P., SE, G., SE, R., JA, P., PS, D. V., JG, B., JP, P., MC, H., K, A., B, W., JA, B., L, A., M, A., S, A., TL, A., CM, B., LF, B., JC, B., BE, C., R, D., H, D., LS, E., YJ, H., MR, I., AT, K., L, L., J, L., RN, L., LW, M., G, M., ME, M., JY, M., D, M., JR, O., ND, P., JM, P., PA, P., AM, S., M, T., FF, W., DE, W., LR, Y., JG, W., G, A., DK, A., LC, B., J, B., E, B., DW, B., YC, C., YI, C., WJ, C., A, C., JE, C., MJ, D., SK, D., PT, E., M, F., BI, F., S, G., S, G., RA, G., J, H., K, H., GP, J., RC, K., SLR, K., E, K., RW, K., C, K., CC, L., S, L., DM, L., RJF, L., SA, L., RA, M., KAV, M., ST, M., BD, M., DA, N., KE, N., A, P., CJ, P., BM, P., DC, R., S, R., AP, R., D, S., JS, S., AV, S., RP, T., RS, V., S, K., LA, C., JI, R., AC, M., SS, R., S, R., C, W., Consortium, N. T. F. P. M. (., FinnGen, & GM, P. (2021). Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.. Nature communications. https://doi.org/10.1038/s41467-021-22339-1

Source records